Article info
Patient safety and risk management
PS-020 The cost-effectiveness of screening for dihydropyrimidine dehydrogenase polymorphisms in cancer patients treated with fluoropyrimidines
Citation
PS-020 The cost-effectiveness of screening for dihydropyrimidine dehydrogenase polymorphisms in cancer patients treated with fluoropyrimidines
Publication history
- First published March 24, 2015.
Online issue publication
May 13, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2015, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions